David R Epstein bought $104K of AGMB stock

David R Epstein, Dir of AgomAb Therapeutics NV (AGMB), bought 15,000 shares of AGMB stock worth $104K, per an SEC Form 4 filed Nov 6, 2026.

It was an open-market purchase.

The trade happened on Nov 5, 2026, 1 day before it was made public.

AGMB has moved +9.5% since the trade date, from $6.97 to $7.63 (Nov 6, 2026 close).